Endoscopic treatment of acute necrotizing pancreatitis - Influence of timing of intervention on treatment success, complications and mortality - a monocentric retrospective analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032583

Enrollment

250

Registered

2023-09-26

Start date

2023-04-15

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K85

Interventions

Group 1: Early intervention ( 4 weeks)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: all consecutive patients (01/2002-06-2021) who underwent endoscopic transluminal debridement for acute necrotising pancreatitis.

Exclusion criteria

Exclusion criteria: Patients < 18 years Endoscopic treatment without debridement

Design outcomes

Primary

Measure	Time frame
Combined primary endpoint of endoscopic treatment success without pancreatitis-associated mortality, without surgery, without major complications	—

Secondary

Measure	Time frame
pancreatitis-associated mortality 28-day mortality after index procedure major bleeding requiring surgery perforation requiring surgery minor bleeding requiring endoscopic treatment stent dislocation Surgery for therapy-refractory necrosis	—

Countries

Germany

Contacts

Public ContactChristian Meinhardt

Klinikum Oldenburg AöR, Universitätsklinik für Innere Medizin - Gastroenterologie, Hepatologie, Stoffwechselmedizin, Nieren- und Hochdruckerkrankungen

Christian.Meinhardt@uni-oldenburg.de+494414032580

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026